Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BAY2701439 |
| Trade Name | |
| Synonyms | BAY-2701439|BAY 2701439|HER2-TTC|227Th Trastuzumab Corixetan |
| Drug Descriptions |
BAY2701439 comprises a monoclonal antibody that targets ERBB2 (HER2) conjugated to a chelator complexed with the radioisotope Th 227, which delivers radiation to ERBB2 (HER2-expressing tumors and has potential antitumor activity (Cancer Res 2021;81(13_Suppl):Abstract nr ND07). |
| DrugClasses | HER2 (ERBB2) Antibody 79 |
| CAS Registry Number | NA |
| NCIT ID | C168996 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| BAY2701439 | BAY2701439 | 0 | 1 |
| BAY2701439 + Olaparib | BAY2701439 Olaparib | 0 | 0 |